Ardeshir Khademi: A Clinical Lesson on Thrombophilia, Silent Infarcts, and Asking the Right Questions
Ardeshir Khademi, Founder and Medical Director at Countryside Neurology, posted on LinkedIn:
” ‘Did you have stroke in the past ?’
‘No, never’
Today, I saw a woman in her 50s whose MRI showed two old cortical infarcts — not tiny lacunes, but clear evidence of past strokes.
When I asked if she’d ever had a stroke, she said:
‘No’
She truly didn’t know. No documented event. No hospitalization. Just silent damage, revealed years later.
She mentioned being Factor V Leiden positive, which usually causes venous clots — not the arterial ones that lead to stroke.
That inconsistency made me ask more questions.
Then came the key detail:
Her sister had antiphospholipid antibody syndrome (APS) — a condition that can cause arterial thrombosis and stroke.
Lesson:
Not all thrombophilias (clotting disorders) are created equal.
• Factor V Leiden → venous
• Antiphospholipid syndrome → arterial ± venous
And sometimes, the brain quietly records a history the patient never knew.
Have you ever found “silent” strokes that rewrote a patient’s story?
— Ardeshir Khademi
Neurology | Brain Health
Countryside Neurology | NeuroVista Insights”
Stay informed with Hemostasis Today.
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease
-
Sep 4, 2026, 11:18Aanika Roshni: When Blood, Biology, and Mechanics Intersect
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk